Jon Congleton

Chief Executive Officer, Director, Mineralys Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$16.2M

Companies

Latest trade

Sep 30, 2026

Companies

Mineralys Therapeutics, Inc.Chief Executive Officer, Director −$16.8M

Trades

MLYS Sold 75,000 shares at $25.46 · planned $1.9M Sep 30

MLYS Sold 10,700 shares at $27.24 · planned $0.3M Jul 13

MLYS Sold 75,000 shares at $26.14 · planned $2.0M Jun 30

MLYS Sold 15,730 shares at $26.83 · planned $0.4M Apr 13

MLYS Sold 75,000 shares at $26.27 · planned $2.0M Mar 31

MLYS Sold 16,236 shares at $32.62 · planned $0.5M Jan 12

MLYS Sold 200,000 shares at $45.44 $9.1M Nov 11

MLYS Sold 15,100 shares at $42.67 · planned $0.6M Oct 13

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.